| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:54 UTC |
|---|
| HMDB ID | HMDB0015200 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glipizide |
|---|
| Description | Glipizide is only found in individuals that have used or taken this drug. It is an oral hypoglycemic agent which is rapidly absorbed and completely metabolized. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. |
|---|
| Structure | CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1 InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28) |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea | ChEBI | | Aldiab | ChEBI | | CP 28,720 | ChEBI | | CP 28720 | ChEBI | | CP-28,720 | ChEBI | | Digrin | ChEBI | | Dipazide | ChEBI | | Glibenese | ChEBI | | Glibetin | ChEBI | | Glican | ChEBI | | Glidiab | ChEBI | | Glipid | ChEBI | | Glipizida | ChEBI | | Glipizidum | ChEBI | | Gluco-rite | ChEBI | | Glucolip | ChEBI | | Glucotrol | ChEBI | | Glucozide | ChEBI | | Glupitel | ChEBI | | Glupizide | ChEBI | | Glyde | ChEBI | | Glydiazinamide | ChEBI | | K 4024 | ChEBI | | Melizide | ChEBI | | Mindiab | ChEBI | | Minidab | ChEBI | | Minidiab | ChEBI | | Minodiab | ChEBI | | N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea | ChEBI | | Napizide | ChEBI | | Ozidia | ChEBI | | Sucrazide | ChEBI | | 1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulphonyl)urea | Generator | | N-{4-[b-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonyl}-n'-cyclohexylurea | Generator | | N-{4-[b-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea | Generator | | N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonyl}-n'-cyclohexylurea | Generator | | N-{4-[β-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonyl}-n'-cyclohexylurea | Generator | | N-{4-[β-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea | Generator | | Glibenese brand OF glipizide | HMDB | | Glidiazinamide | HMDB | | Glypidizine | HMDB | | Kenfarma brand OF glipizide | HMDB | | Pfizer brand 2 OF glipizide | HMDB | | Alphapharm brand OF glipizide | HMDB | | Lacer brand OF glipizide | HMDB | | Pfizer brand 1 OF glipizide | HMDB | | Glipizide kenfarma brand | HMDB | | Lilly brand OF glipizide | HMDB |
|
|---|
| Chemical Formula | C21H27N5O4S |
|---|
| Average Molecular Weight | 445.535 |
|---|
| Monoisotopic Molecular Weight | 445.178375067 |
|---|
| IUPAC Name | N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide |
|---|
| Traditional Name | glipizide |
|---|
| CAS Registry Number | 29094-61-9 |
|---|
| SMILES | CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1 |
|---|
| InChI Identifier | InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28) |
|---|
| InChI Key | ZJJXGWJIGJFDTL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Benzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Sulfonylurea
- Pyrazine
- Organic sulfonic acid or derivatives
- Heteroaromatic compound
- Aminosulfonyl compound
- Sulfonyl
- Organosulfonic acid or derivatives
- Carboximidic acid
- Carboximidic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 208 - 209 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.016 g/L | Not Available | | LogP | 2.5 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.15 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.0541 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.7 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1564.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 188.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 174.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 105.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 319.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 437.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 414.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 989.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 357.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1315.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 269.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 303.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 343.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 269.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 146.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glipizide,1TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C)C=N1 | 4068.9 | Semi standard non polar | 33892256 | | Glipizide,1TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C)C=N1 | 3268.5 | Standard non polar | 33892256 | | Glipizide,1TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C)C=N1 | 5592.8 | Standard polar | 33892256 | | Glipizide,1TMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 3942.8 | Semi standard non polar | 33892256 | | Glipizide,1TMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 3243.6 | Standard non polar | 33892256 | | Glipizide,1TMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 5736.6 | Standard polar | 33892256 | | Glipizide,1TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 3890.7 | Semi standard non polar | 33892256 | | Glipizide,1TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 3274.0 | Standard non polar | 33892256 | | Glipizide,1TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)C=N1 | 5692.8 | Standard polar | 33892256 | | Glipizide,2TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3839.3 | Semi standard non polar | 33892256 | | Glipizide,2TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3410.9 | Standard non polar | 33892256 | | Glipizide,2TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 5403.8 | Standard polar | 33892256 | | Glipizide,2TMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3768.5 | Semi standard non polar | 33892256 | | Glipizide,2TMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3433.6 | Standard non polar | 33892256 | | Glipizide,2TMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 5285.3 | Standard polar | 33892256 | | Glipizide,2TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C=N1 | 3725.6 | Semi standard non polar | 33892256 | | Glipizide,2TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C=N1 | 3474.6 | Standard non polar | 33892256 | | Glipizide,2TMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C=N1 | 5407.5 | Standard polar | 33892256 | | Glipizide,3TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3682.4 | Semi standard non polar | 33892256 | | Glipizide,3TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 3662.5 | Standard non polar | 33892256 | | Glipizide,3TMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C=N1 | 4984.1 | Standard polar | 33892256 | | Glipizide,1TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4314.0 | Semi standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 3448.7 | Standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 5608.5 | Standard polar | 33892256 | | Glipizide,1TBDMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4192.7 | Semi standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 3430.5 | Standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #2 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 5735.8 | Standard polar | 33892256 | | Glipizide,1TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4140.4 | Semi standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 3482.0 | Standard non polar | 33892256 | | Glipizide,1TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 5676.4 | Standard polar | 33892256 | | Glipizide,2TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4340.8 | Semi standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 3783.8 | Standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 5356.5 | Standard polar | 33892256 | | Glipizide,2TBDMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4260.3 | Semi standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 3827.3 | Standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #2 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 5223.3 | Standard polar | 33892256 | | Glipizide,2TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4246.7 | Semi standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 3882.4 | Standard non polar | 33892256 | | Glipizide,2TBDMS,isomer #3 | CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 5359.3 | Standard polar | 33892256 | | Glipizide,3TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4394.9 | Semi standard non polar | 33892256 | | Glipizide,3TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4250.7 | Standard non polar | 33892256 | | Glipizide,3TBDMS,isomer #1 | CC1=CN=C(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCCCC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C=N1 | 4980.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Glipizide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udj-9433200000-0daa174c6f208f739d92 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glipizide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide LC-ESI-qTof , Positive-QTOF | splash10-014i-0119600000-895a0f8ef34678f1200d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide LC-ESI-qTof , Positive-QTOF | splash10-014i-0009600000-3a2ab7e8e725ab4b2090 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide LC-ESI-qTof , Positive-QTOF | splash10-0v4i-3941000000-57ab7532afaad5f9a2ac | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide , positive-QTOF | splash10-014i-0009600000-3a2ab7e8e725ab4b2090 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide , positive-QTOF | splash10-00di-0329000000-a6f7044e9dfe397cfcdd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide , positive-QTOF | splash10-014i-0119600000-895a0f8ef34678f1200d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide , positive-QTOF | splash10-00di-1429000000-60bdb648d5355af7a75b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide , positive-QTOF | splash10-0v4i-3941000000-57ab7532afaad5f9a2ac | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 60V, Negative-QTOF | splash10-00bc-9400000000-e36d6f6a0eb4114e661c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 45V, Negative-QTOF | splash10-00di-3900000000-e23bb49f877be3901320 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 75V, Negative-QTOF | splash10-004l-9100000000-688c676b3e072ae42071 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 90V, Negative-QTOF | splash10-01tc-9100000000-4c0399e69298b606717a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 30V, Positive-QTOF | splash10-0gi9-0946000000-e87ed6360a6302adddaf | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 60V, Positive-QTOF | splash10-0w30-1900000000-b3353b86c5a566797995 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 90V, Positive-QTOF | splash10-01tc-9100000000-1058c878e881b259b2e6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 45V, Positive-QTOF | splash10-0gc9-0910000000-97927d7e80b6e6c9c189 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 30V, Positive-QTOF | splash10-0gi9-0946000000-1bd55371a0002464d88d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 45V, Positive-QTOF | splash10-0gc9-0910000000-4c6c3446c687a5f55469 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glipizide 60V, Positive-QTOF | splash10-0w30-1900000000-91618f445cb7066cc191 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 10V, Positive-QTOF | splash10-006t-1209300000-c14d0f75f56599ec527f | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 20V, Positive-QTOF | splash10-0002-7903000000-63e0326a933897ad8d58 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 40V, Positive-QTOF | splash10-05mk-9700000000-3dea1f33244b9e19e407 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 10V, Negative-QTOF | splash10-0007-5208900000-36b94e0ee176fc17450f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 20V, Negative-QTOF | splash10-00kb-4529000000-18be67f87a3195a21fff | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glipizide 40V, Negative-QTOF | splash10-0007-9310000000-3bae0e1f24a4fc985c6b | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|